Search - tctmd.com

Displaying 21 - 40 of 197

Sort: Relevancy | Date

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

News Daily News

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Michael O'Riordan

July 18, 2025

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

News Daily News

PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes

July 14, 2025

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

June 25, 2025

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

Majority of US Adults Have High Long-term Risk of CVD: NHANES

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Michael O'Riordan

June 13, 2025

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

June 12, 2025

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

News Daily News

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

June 06, 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

News Conference News European Congress on Obesity 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Michael O'Riordan

May 14, 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

Access to GLP-1 Drugs Unequal for US Patients With Obesity

News Daily News

Access to GLP-1 Drugs Unequal for US Patients With Obesity

May 01, 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

News Conference News HRS 2025

GLP-1 Drugs May Have Role in Secondary Prevention of AF

April 28, 2025

Medicaid Patients with Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

February 12, 2025

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

January 31, 2025

January 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

January 24, 2025

European Medicines Agency Investigating GLP-1 Drugs and Eye Disease

News Daily News

European Medicines Agency Investigating GLP-1 Drugs and Eye Disease

January 21, 2025

Misleading Statements Common in Online Ads for Compounded GLP-1s

News Daily News

Misleading Statements Common in Online Ads for Compounded GLP-1s

January 20, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.